News | April 22, 2009

HRS Reiterates Positive Correlation Between EP Certification, Improved ICD Outcomes

April 22, 2009 – In response to the article “Association of Physician Certification and Outcomes Among Patients Receiving an Implantable Cardioverter-Defibrillator,” published in the April 22 issue of the JAMA, the Heart Rhythm Society reiterates its position on the positive correlation between electrophysiology certification and improved outcomes following ICD implantation.

The study used cases submitted to the ICD Registry, which was created by the Heart Rhythm Society and the American College of Cardiology Foundation to collect detailed information on ICD implantations to assess and improve the care of patients receiving ICDs for primary prevention therapy.

The authors compared patient outcomes based on the certification status of the implanting physician: electrophysiologist, non-electrophysiologist cardiologist, thoracic surgeon and other specialists. Overall implantations by a non-electrophysiologist were associated with a higher risk of procedural complications compared to ICDs implanted by an electrophysiologist. Patients of non-electrophysiologists were also less likely to receive a CRT-D device when indicated compared to patients of electrophysiologists.

“This important study confirms the Society’s position that trained and experienced electrophysiologists are best equipped to provide optimal care for patients who need life-saving ICD or CRT-D therapy,” said N.A. Mark Estes, president of the Heart Rhythm Society. “Specialized training enables physicians to not only implant devices with a lower risk of procedural complications, but also select the most appropriate device-based therapy for each patient.”

The analysis also examined the geographic distribution of ICD implants, and found that the majority of ICD implants performed by nonelectrophysiologists took place at or relatively near hospitals in which an electrophysiologist also implanted ICDs.

The Heart Rhythm Society strongly recommends that all physicians and credentialing bodies follow the training guidance found in the ACC/ACP/AHA/HRS Recommendations for Training in Adult Cardiovascular Medicine Core Cardiology Training (COCATS) 3: Task Force 6 Training in Specialized Electrophysiology, Cardiac Pacing, and Arrhythmia Management.

For more information: http://jama.ama-assn.org/cgi/content/full/301/16/1661, www.hrsonline.org


Related Content

News | Implantable Cardioverter Defibrillator (ICD)

February 12, 2024 — BIOTRONIK, a leader in implantable medical device technology, announced today they will solely ...

Home February 12, 2024
Home
News | Implantable Cardioverter Defibrillator (ICD)

October 23, 2023 — Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug ...

Home October 23, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Is the routine implantation of an implantable cardioverter defibrillator (ICD) in myocardial ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 28, 2023 — Upgrade to cardiac resynchronization therapy with a defibrillator (CRT-D) reduces morbidity and ...

Home August 28, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Medtronic ICDs and CRT-Ds ...

Home July 18, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

March 7, 2023 — Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no ...

Home March 07, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

February 17, 2023 — Medtronic plc has received CE (Conformité Européenne) Mark for the Aurora EV-ICD MRI SureScan ...

Home February 17, 2023
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

Home August 29, 2022
Home
News | Implantable Cardioverter Defibrillator (ICD)

August 18, 2022 — A first-in-human multicenter trial involving Mayo Clinic used a new ablation technique for patients ...

Home August 18, 2022
Home
Subscribe Now